Developer docs
API playgroundTry for free, no card

Search company profiles

S-Cubed

Full company profile

uuid000s1qw

Namestring
S-Cubed
Legal namestring
S-CUBED LTD
Company typeenum
Private
Founded yearint
2002
Descriptiontext

S-Cubed Ltd is a privately held UK-headquartered pharmaceutical clinical research consulting firm founded in 2002 and based in Wantage (Oxford), serving more than 25 leading pharmaceutical and biotech companies. The firm operates as a professional services consultancy providing Regulatory Affairs, Biometrics (covering data management, SAS and statistical programming, biostatistics, and CDISC standards implementation including SDTM and ADaM), Quality Assurance, and Project Management services for clinical studies through to regulatory submissions support. Its go-to-market is sales-led and consultative, driven by thought leadership (quarterly Industry Insights newsletters covering EMA, FDA, EDQM, and ICH developments), active participation in CDISC EU Interchanges (where it holds Sapphire sponsorship), and senior-staff domain credentials including certified CDISC trainers and members of the European CDISC Coordinating Committee.

Following the January 2023 divestiture of S-cubed Denmark (ApS) to Phastar, S-cubed Ltd and S-cubed Biometrics Ltd continued to operate independently. In January 2025, S-cubed Ltd joined the athagoras group, a strategic combination explicitly intended to broaden the range of services offered to existing clients. Pricing is not publicly disclosed and operates on a quote-based, project-scoped professional services model targeting enterprise pharma and biotech buyers across the United Kingdom and broader European market. There is no evidence of AI/ML, proprietary software products, or platform technology; the value proposition rests on specialist human expertise in regulatory affairs, CDISC standards, and biometrics delivery.

Short descriptiontext

S-Cubed Ltd is a UK-based pharmaceutical clinical research consultancy providing regulatory affairs, biometrics, CDISC standards implementation (SDTM/ADaM), biostatistics, quality assurance, and project management services to more than 25 pharmaceutical and biotech companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWantage, United Kingdom
HQ citystring
Wantage
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical regulatory consulting, clinical biometrics services, CDISC standards implementation, biostatistics programming, clinical research consultancy
Industry3 codes
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Regulatory & Clinical Research Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Regulatory Affairs Consulting
TypeProfessional Services
Description

Regulatory affairs consultancy services encompassing new chemical entities, biological entities, generic compounds, and therapies for orphan indications

s-cubed-global.com
2Biometrics Services
TypeProfessional Services
Description

Full range of biometrics services including data management, analysis, reporting activities, SAS and statistical programming

s-cubed-global.com
3Quality Assurance Services
TypeProfessional Services
Description

Quality systems development, compliance verification, and work quality verification services

s-cubed-global.com
4Project Management
TypeProfessional Services
Description

Project management services for clinical studies

s-cubed-global.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

S-Cubed provides professional consulting and contract services to pharmaceutical and biotech companies for clinical research, covering regulatory affairs for new chemical entities, biologicals, generics and orphan therapies, biometrics and biostatistics for clinical trial data management, SAS and statistical programming, CDISC standards implementation (SDTM, ADaM), quality assurance, and project management for clinical development studies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • EDQM publishes new guidance on reliance-based and fast-track assessment of CEP applications: procedures aim to shorten approval timelines from 15-22 months to 4-6 months
Product overview1 text field

S-cubed is a pharmaceutical industry clinical research consulting company offering flexible consultancy solutions and full biometrics CRO services. The core service portfolio includes Regulatory Affairs, Biometrics (encompassing SAS & Statistical Programming and Biostatistics), Quality Assurance, and Project Management. The company also provides CDISC standards implementation services (SDTM/ADaM) and publishes quarterly Industry Insights newsletters on clinical development regulations. The company operates independently in the UK (S-cubed Ltd for regulatory affairs and S-cubed Biometrics Ltd) following the 2023 acquisition of S-cubed Denmark (ApS) by Phastar.

Product and service8 records
1Regulatory Affairs
CategoryRegulatory Consulting
Description

Comprehensive regulatory expertise for pharmaceutical and biotech companies, encompassing new chemical entities, biological entities, medicinal products containing established active ingredients, generic compounds, and therapies for orphan indications.

2Biometrics
CategoryClinical Biometrics Services
Description

Full range of biometrics, data management, analysis, and reporting activities covering individual clinical studies through to integrated databases and regulatory submissions support.

3SAS & Statistical Programming
CategoryStatistical Programming
Description

Specialist statistical programming services delivered as part of the biometrics offering, supporting clinical study data analysis and regulatory submissions using SAS.

4Biostatistics
CategoryStatistical Analysis
Description

Statistical analysis services for clinical trials and pharmaceutical research, integrated with the broader biometrics service offering.

5Quality Assurance
CategoryQuality Assurance
Description

Quality systems development, compliance verification of existing systems, and quality of work verification services for pharmaceutical and biotech companies.

6Project Management
CategoryClinical Project Management
Description

Accomplished project managers with the knowledge, competences, and qualifications to mitigate risks and create practical solutions across small, large, and multiple clinical development projects, integrating seamlessly with client teams.

7CDISC Implementation Services
CategoryData Standards Implementation
Description

CDISC standards implementation services including SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) for clinical trial data standardization, alongside legacy data conversion and authorized CDISC training.

8Industry Insights Newsletter
CategoryRegulatory Intelligence / Content
Description

Quarterly regulatory newsletter covering EU, UK, US and international pharmaceutical regulations, ICH guidelines, FDA guidance, clinical trial developments, and real-world data and evidence updates.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

S-cubed Ltd joined the athagoras group in January 2025. This strategic move allows expansion of the range of services offered to existing clients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global biometrics, statistical programming, and regulatory CRO for pharma and biotech. Direct peer because Phastar acquired S-Cubed's Denmark subsidiary in 2023 and competes in the same biometrics, SAS programming, and CDISC implementation space.

TypeDirect peer
Description

Clinical research services organization focused on data management, biostatistics, regulatory, and pharmacovigilance for pharma and biotech. Direct peer with overlapping CDISC-aware biometrics and regulatory submission services.

TypeBroad incumbent
Description

Mid-size global CRO providing clinical trial management, biometrics, and regulatory affairs across multiple therapeutic areas. Broader incumbent competing for biometrics and regulatory consulting work alongside larger full-service CROs.

TypeDirect peer
Description

UK-headquartered biostatistics and biometrics CRO for pharma, biotech, and medical device companies. Direct peer matching S-Cubed's biometrics, statistical programming, and regulatory consulting focus in a similar UK-based delivery footprint.

TypeEmerging player
Description

Technology-enabled CRO and software provider offering CDISC standards implementation, regulatory submission software, and clinical data services. Comparable to S-Cubed for CDISC and regulatory submission work with a more software-centric delivery model.

TypeBroad incumbent
Description

Full-service global CRO offering clinical development, biometrics, biostatistics, and regulatory services. Broader incumbent that competes with S-Cubed for biometrics and regulatory consulting budgets as part of integrated CRO engagements.

TypeDirect peer
Description

Specialized biometrics and biostatistics CRO serving pharma and biotech with statistical programming, CDISC-compliant data, and clinical trial analytics. Directly comparable to S-Cubed's biometrics and biostatistics offering with an overlapping client base.

TypeDirect peer
Description

UK-based biostatistics, statistical programming, and CDISC consultancy serving pharma and biotech. Direct peer with a similar small-to-mid-sized UK delivery focus on biometrics and CDISC standards (SDTM, ADaM).

TypeBroad incumbent
Description

Mid-size CRO offering clinical operations, biostatistics, data management, and regulatory services to pharma and biotech. Broader incumbent that overlaps with S-Cubed's biometrics and regulatory consulting capabilities.

10Rho
TypeEmerging player
Description

Mid-size CRO and consulting firm with strong biostatistics, regulatory affairs, and CDISC expertise serving small and mid-sized biopharma. Comparable to S-Cubed as a specialized smaller consultancy competing for similar biometrics engagements.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

S-Cubed

Pharmaceutical Regulatory & Clinical Research Consultings-cubed-global.com

S-Cubed Ltd is a UK-based pharmaceutical clinical research consultancy providing regulatory affairs, biometrics, CDISC standards implementation (SDTM/ADaM), biostatistics, quality assurance, and project management services to more than 25 pharmaceutical and biotech companies.

What S-Cubed does

S-Cubed Ltd is a privately held UK-headquartered pharmaceutical clinical research consulting firm founded in 2002 and based in Wantage (Oxford), serving more than 25 leading pharmaceutical and biotech companies. The firm operates as a professional services consultancy providing Regulatory Affairs, Biometrics (covering data management, SAS and statistical programming, biostatistics, and CDISC standards implementation including SDTM and ADaM), Quality Assurance, and Project Management services for clinical studies through to regulatory submissions support. Its go-to-market is sales-led and consultative, driven by thought leadership (quarterly Industry Insights newsletters covering EMA, FDA, EDQM, and ICH developments), active participation in CDISC EU Interchanges (where it holds Sapphire sponsorship), and senior-staff domain credentials including certified CDISC trainers and members of the European CDISC Coordinating Committee.

Following the January 2023 divestiture of S-cubed Denmark (ApS) to Phastar, S-cubed Ltd and S-cubed Biometrics Ltd continued to operate independently. In January 2025, S-cubed Ltd joined the athagoras group, a strategic combination explicitly intended to broaden the range of services offered to existing clients. Pricing is not publicly disclosed and operates on a quote-based, project-scoped professional services model targeting enterprise pharma and biotech buyers across the United Kingdom and broader European market. There is no evidence of AI/ML, proprietary software products, or platform technology; the value proposition rests on specialist human expertise in regulatory affairs, CDISC standards, and biometrics delivery.

S-Cubed firmographics

Firmographics
Name
S-Cubed
Legal name
S-CUBED LTD
Website
https://s-cubed-global.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
S-Cubed Ltd is a UK-based pharmaceutical clinical research consultancy providing regulatory affairs, biometrics, CDISC standards implementation (SDTM/ADaM), biostatistics, quality assurance, and project management services to more than 25 pharmaceutical and biotech companies.
Ownership category
akta.pro rank

S-Cubed industry classification

Industry
Product category
Pharmaceutical Regulatory & Clinical Research Consulting
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pharmaceutical regulatory consulting
  • Clinical biometrics services
  • CDISC standards implementation
  • Biostatistics programming
  • Clinical research consultancy

Where S-Cubed is headquartered

Location

Headquarters

HQ city
Wantage
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

S-Cubed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regulatory Affairs Consulting: Regulatory affairs consultancy services encompassing new chemical entities, biological entities, generic compounds, and therapies for orphan indications
  2. Biometrics Services: Full range of biometrics services including data management, analysis, reporting activities, SAS and statistical programming
  3. Quality Assurance Services: Quality systems development, compliance verification, and work quality verification services
  4. Project Management: Project management services for clinical studies

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

S-Cubed product offering

Product offering

Core offering

S-Cubed provides professional consulting and contract services to pharmaceutical and biotech companies for clinical research, covering regulatory affairs for new chemical entities, biologicals, generics and orphan therapies, biometrics and biostatistics for clinical trial data management, SAS and statistical programming, CDISC standards implementation (SDTM, ADaM), quality assurance, and project management for clinical development studies.

Product overview

S-cubed is a pharmaceutical industry clinical research consulting company offering flexible consultancy solutions and full biometrics CRO services. The core service portfolio includes Regulatory Affairs, Biometrics (encompassing SAS & Statistical Programming and Biostatistics), Quality Assurance, and Project Management. The company also provides CDISC standards implementation services (SDTM/ADaM) and publishes quarterly Industry Insights newsletters on clinical development regulations. The company operates independently in the UK (S-cubed Ltd for regulatory affairs and S-cubed Biometrics Ltd) following the 2023 acquisition of S-cubed Denmark (ApS) by Phastar.

Differentiator

Problem solved

Functional benefit

Products and services

  • Regulatory Affairs Comprehensive regulatory expertise for pharmaceutical and biotech companies, encompassing new chemical entities, biological entities, medicinal products containing established active ingredients, generic compounds, and therapies for orphan indications.
  • Biometrics Full range of biometrics, data management, analysis, and reporting activities covering individual clinical studies through to integrated databases and regulatory submissions support.
  • SAS & Statistical Programming Specialist statistical programming services delivered as part of the biometrics offering, supporting clinical study data analysis and regulatory submissions using SAS.
  • Biostatistics Statistical analysis services for clinical trials and pharmaceutical research, integrated with the broader biometrics service offering.
  • Quality Assurance Quality systems development, compliance verification of existing systems, and quality of work verification services for pharmaceutical and biotech companies.
  • Project Management Accomplished project managers with the knowledge, competences, and qualifications to mitigate risks and create practical solutions across small, large, and multiple clinical development projects, integrating seamlessly with client teams.
  • CDISC Implementation Services CDISC standards implementation services including SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) for clinical trial data standardization, alongside legacy data conversion and authorized CDISC training.
  • Industry Insights Newsletter Quarterly regulatory newsletter covering EU, UK, US and international pharmaceutical regulations, ICH guidelines, FDA guidance, clinical trial developments, and real-world data and evidence updates.

Quantifiable outcome

  • EDQM publishes new guidance on reliance-based and fast-track assessment of CEP applications: procedures aim to shorten approval timelines from 15-22 months to 4-6 months

Companies that use S-Cubed

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

S-Cubed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

S-Cubed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • athagoras groupcoreStrategic or Co-development Partner · 1 January 2025S-cubed Ltd joined the athagoras group in January 2025. This strategic move allows expansion of the range of services offered to existing clients.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

S-Cubed competitors and assessment

Company assessment

Direct peers

  • Phastar: Global biometrics, statistical programming, and regulatory CRO for pharma and biotech. Direct peer because Phastar acquired S-Cubed's Denmark subsidiary in 2023 and competes in the same biometrics, SAS programming, and CDISC implementation space.
  • MMS Holdings: Clinical research services organization focused on data management, biostatistics, regulatory, and pharmacovigilance for pharma and biotech. Direct peer with overlapping CDISC-aware biometrics and regulatory submission services.
  • Quanticate: UK-headquartered biostatistics and biometrics CRO for pharma, biotech, and medical device companies. Direct peer matching S-Cubed's biometrics, statistical programming, and regulatory consulting focus in a similar UK-based delivery footprint.
  • Cytel: Specialized biometrics and biostatistics CRO serving pharma and biotech with statistical programming, CDISC-compliant data, and clinical trial analytics. Directly comparable to S-Cubed's biometrics and biostatistics offering with an overlapping client base.
  • Veramed: UK-based biostatistics, statistical programming, and CDISC consultancy serving pharma and biotech. Direct peer with a similar small-to-mid-sized UK delivery focus on biometrics and CDISC standards (SDTM, ADaM).

Broad incumbents

  • Worldwide Clinical Trials: Mid-size global CRO providing clinical trial management, biometrics, and regulatory affairs across multiple therapeutic areas. Broader incumbent competing for biometrics and regulatory consulting work alongside larger full-service CROs.
  • Premier Research: Full-service global CRO offering clinical development, biometrics, biostatistics, and regulatory services. Broader incumbent that competes with S-Cubed for biometrics and regulatory consulting budgets as part of integrated CRO engagements.
  • Clinipace Worldwide: Mid-size CRO offering clinical operations, biostatistics, data management, and regulatory services to pharma and biotech. Broader incumbent that overlaps with S-Cubed's biometrics and regulatory consulting capabilities.

Emerging players

  • Instem: Technology-enabled CRO and software provider offering CDISC standards implementation, regulatory submission software, and clinical data services. Comparable to S-Cubed for CDISC and regulatory submission work with a more software-centric delivery model.
  • Rho: Mid-size CRO and consulting firm with strong biostatistics, regulatory affairs, and CDISC expertise serving small and mid-sized biopharma. Comparable to S-Cubed as a specialized smaller consultancy competing for similar biometrics engagements.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

S-Cubed social profiles

Digital presence

S-Cubed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

S-Cubed leadership team

Management profile

Number of profiles

Profiles7 records

S-Cubed subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

S-Cubed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

S-Cubed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about S-Cubed

What does S-Cubed do?

S-Cubed provides professional consulting and contract services to pharmaceutical and biotech companies for clinical research, covering regulatory affairs for new chemical entities, biologicals, generics and orphan therapies, biometrics and biostatistics for clinical trial data management, SAS and statistical programming, CDISC standards implementation (SDTM, ADaM), quality assurance, and project management for clinical development studies.

Is S-Cubed a public or private company?

S-Cubed is a private company. It is classified as corporate owned and is currently operating.

When was S-Cubed founded?

S-Cubed was founded in 2002. It employs 11 to 50 people.

Where is S-Cubed based?

S-Cubed is headquartered in Wantage, United Kingdom, in the Europe region.

How does S-Cubed make money?

Four revenue lines are on record. Regulatory Affairs Consulting is the primary driver. The others are biometrics Services, quality Assurance Services and project Management.

Who are S-Cubed's main competitors?

Direct peers on record are Phastar, MMS Holdings, Quanticate, Cytel and Veramed. Broad incumbents are Worldwide Clinical Trials, Premier Research and Clinipace Worldwide. Emerging players are Instem and Rho.

Does S-Cubed have an API?

No public API is recorded for S-Cubed.

What industry is S-Cubed in?

S-Cubed's product category is Pharmaceutical Regulatory & Clinical Research Consulting. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooClinical Trial Data Visualization Research Report 2026: $1.82 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035FResearchAndMarkets.com has released its Clinical Trial Data Visualization Market Report 2026, projecting the market to grow from $0.89 billion in 2025 to $1.82 billion by 2030, driven by a compound annual growth rate of approximately 15%. The report highlights key growth drivers including increasing clinical trial data complexity, expansion of decentralized trials, and rising adoption of AI-powered and cloud-based analytics solutions. Notable industry developments include Medidata Solutions' June 2024 launch of its AI-enabled Clinical Data Studio platform and Phastar's acquisition of S-cubed ApS in January 2023 to strengthen its data visualization capabilities.PhastarPhastar Enhances Data Visualisation and Analytics Solution Through Acquisition of S-Cubed ApSPhastar announced the acquisition of S-Cubed ApS, a specialist biometrics and data visualisation company based in Denmark. This transaction expands Phastar's workforce to approximately 550 employees globally and strengthens its operational presence in the Nordic region while enhancing its data analytics capabilities.PR NewswirePhastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in DenmarkPhastar has acquired S-Cubed ApS, a company specializing in biometrics and data visualization, enhancing Phastar's capabilities in the Nordic region. This acquisition increases the PHASTAR group to approximately 550 employees and is expected to improve service delivery for customers in the area. The collaboration aims to address the growing data challenges in the life sciences sector, incorporating advanced visualization and analytical tools.